BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31678978)

  • 1. Successful Eradication of Helicobacter pylori Could Prevent Metachronous Gastric Cancer: A Propensity Matching Analysis.
    Nakata R; Nagami Y; Hashimoto A; Sakai T; Ominami M; Fukunaga S; Otani K; Hosomi S; Tanaka F; Ohira M; Taira K; Yamagami H; Tanigawa T; Watanabe T; Fujiwara Y
    Digestion; 2021; 102(2):236-245. PubMed ID: 31678978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of metachronous gastric cancer in patients whose primary gastric neoplasms were discovered after Helicobacter pylori eradication.
    Okada K; Suzuki S; Naito S; Yamada Y; Haruki S; Kubota M; Nakajima Y; Shimizu T; Ando K; Uchida Y; Hirasawa T; Fujisaki J; Tsuchida T
    Gastrointest Endosc; 2019 Jun; 89(6):1152-1159.e1. PubMed ID: 30825537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between
    Kim SB; Lee SH; Bae SI; Jeong YH; Sohn SH; Kim KO; Jang BI; Kim TN
    World J Gastroenterol; 2016 Nov; 22(44):9794-9802. PubMed ID: 27956803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful Helicobacter pylori eradication: results of a large-scale, multicenter cohort study in Japan.
    Mori G; Nakajima T; Asada K; Shimazu T; Yamamichi N; Maekita T; Yokoi C; Fujishiro M; Gotoda T; Ichinose M; Ushijima T; Oda I
    Gastric Cancer; 2016 Jul; 19(3):911-8. PubMed ID: 26420267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer.
    Maehata Y; Nakamura S; Fujisawa K; Esaki M; Moriyama T; Asano K; Fuyuno Y; Yamaguchi K; Egashira I; Kim H; Kanda M; Hirahashi M; Matsumoto T
    Gastrointest Endosc; 2012 Jan; 75(1):39-46. PubMed ID: 22018552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of Helicobacter pylori eradication and age are independent risk factors for recurrent neoplasia after endoscopic resection of early gastric cancer in 283 patients.
    Kwon YH; Heo J; Lee HS; Cho CM; Jeon SW
    Aliment Pharmacol Ther; 2014 Mar; 39(6):609-18. PubMed ID: 24461252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori Eradication for Prevention of Metachronous Recurrence after Endoscopic Resection of Early Gastric Cancer.
    Bang CS; Baik GH; Shin IS; Kim JB; Suk KT; Yoon JH; Kim YS; Kim DJ
    J Korean Med Sci; 2015 Jun; 30(6):749-56. PubMed ID: 26028928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Helicobacter pylori eradication for metachronous gastric cancer prevention: a randomized controlled trial.
    Choi JM; Kim SG; Choi J; Park JY; Oh S; Yang HJ; Lim JH; Im JP; Kim JS; Jung HC
    Gastrointest Endosc; 2018 Sep; 88(3):475-485.e2. PubMed ID: 29800546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing metachronous gastric lesions after endoscopic submucosal dissection through Helicobacter pylori eradication.
    Jung S; Park CH; Kim EH; Shin SJ; Chung H; Lee H; Park JC; Shin SK; Lee YC; Lee SK
    J Gastroenterol Hepatol; 2015 Jan; 30(1):75-81. PubMed ID: 25088761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection.
    Kwon Y; Jeon S; Nam S; Shin I
    Aliment Pharmacol Ther; 2017 Oct; 46(8):758-767. PubMed ID: 28799258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of metachronous gastric cancer after endoscopic submucosal dissection associated with eradication status of Helicobacter pylori.
    Ikeda R; Hirasawa K; Sato C; Sawada A; Nishio M; Fukuchi T; Kobayashi R; Makazu M; Kaneko H; Maeda S
    Eur J Gastroenterol Hepatol; 2021 Jan; 33(1):17-24. PubMed ID: 32483085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric Cancer with Submucosal Invasion after Successful Helicobacter pylori Eradication: A Propensity Score-Matched Analysis of Patients with Annual Patient Endoscopic Survey.
    Hata K; Ito M; Boda T; Kotachi T; Kiso M; Masuda K; Kurihara M; Kuroki K; Yorita N; Nagasaki N; Abduwali M; Tanaka S; Chayama K
    Digestion; 2019; 99(1):59-65. PubMed ID: 30554223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori Eradication Prevents Metachronous Gastric Neoplasms after Endoscopic Resection of Gastric Dysplasia.
    Shin SH; Jung DH; Kim JH; Chung HS; Park JC; Shin SK; Lee SK; Lee YC
    PLoS One; 2015; 10(11):e0143257. PubMed ID: 26580072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between Helicobacter pylori status and incidence of metachronous gastric cancer after endoscopic resection of early gastric cancer.
    Kim YI; Choi IJ; Kook MC; Cho SJ; Lee JY; Kim CG; Ryu KW; Kim YW
    Helicobacter; 2014 Jun; 19(3):194-201. PubMed ID: 24612125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Helicobacter pylori eradication on metachronous recurrence after endoscopic resection of gastric neoplasm.
    Bae SE; Jung HY; Kang J; Park YS; Baek S; Jung JH; Choi JY; Kim MY; Ahn JY; Choi KS; Kim DH; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH
    Am J Gastroenterol; 2014 Jan; 109(1):60-7. PubMed ID: 24343545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori eradication prevents secondary gastric cancer in patients with mild-to-moderate atrophic gastritis.
    Kato M; Hayashi Y; Nishida T; Oshita M; Nakanishi F; Yamaguchi S; Kitamura S; Nishihara A; Akasaka T; Ogiyama H; Nakahara M; Yamada T; Kishida O; Yamamoto M; Shimayoshi A; Tsujii Y; Kato M; Shinzaki S; Iijima H; Takehara T
    J Gastroenterol Hepatol; 2021 Aug; 36(8):2083-2090. PubMed ID: 33403702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of Primary and Metachronous Gastric Cancers Discovered after
    Maehata Y; Nakamura S; Esaki M; Ikeda F; Moriyama T; Hida R; Washio E; Umeno J; Hirahashi M; Kitazono T; Matsumoto T
    Gut Liver; 2017 Sep; 11(5):628-634. PubMed ID: 28395508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristic analysis of early gastric cancer after
    Liu X; Wang X; Mao T; Yin X; Wei Z; Fu J; Wu J; Li X
    Ann Med; 2023 Dec; 55(1):2231852. PubMed ID: 37450336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum pepsinogen levels can quantify the risk of development of metachronous gastric cancer after endoscopic resection.
    Iguchi M; Kato J; Yoshida T; Yamamoto Y; Nakachi K; Fukatsu K; Mori Y; Maeda Y; Moribata K; Shingaki N; Niwa T; Deguchi H; Inoue I; Maekita T; Tamai H; Ichinose M
    Int J Cancer; 2016 Sep; 139(5):1150-6. PubMed ID: 27083518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Effects of
    Han SJ; Kim SG; Lim JH; Choi JM; Oh S; Park JY; Kim J; Kim JS; Jung HC
    Gut Liver; 2018 Mar; 12(2):133-141. PubMed ID: 29069890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.